April 25, 2025 FDA Approves Penpulimab-kcqx for NPC The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma. Conexiant
April 16, 2025 RSV Vaccine Access Under CDC Review “An estimated 15,000–20,000 annual RSV-associated hospitalizations occur in adults aged 50–59”—prompting CDC advisers to revisit age-based vaccine recommendations. Reuters
April 04, 2025 First IgG4-RD Treatment Approved A humanized monoclonal antibody that targets CD19+ B cells is first FDA-approved treatment for immunoglobulin G4–related disease, reducing flare risk and glucocorticoid use in clinical trials. Conexiant
April 02, 2025 FDA Misses Novavax Decision Date FDA misses April 1 deadline for deciding on Novavax's COVID-19 vaccine. Reuters
April 02, 2025 FDA Approves Automated Latent TB Test Revvity’s Auto-Pure 2400 platform for use with the T-SPOT.TB test to automate latent tuberculosis diagnostics was approved by the FDA. Conexiant